I have not seen it in any of the 8Ks, quarterly or
Post# of 15624
(Total Views: 650)
Posted On: 04/15/2017 9:25:37 PM
Re: Running High #6933
I have not seen it in any of the 8Ks, quarterly or annual reports. The following link contains a Business Information Report for Teva Pharmaceutical Industries Ltd. provided by Dun & Bradstreet.
To OWCP's credit they did not want to report something that they were obviously not interested in pursuing, and that may have fuelled unnecessary speculation. I say good for OWCP!!!
https://www.dnb.com.tw/Report/Sample/BIR_Israel.pdf
You will find the following on page 3 of 8
20/07/2015:
Further to the info that subject approached One World Cannabis in order to
start negotiations for the purchase of patents, it should be noted that
companies engaged in the line and mainly traded on the NYSE, surge by tens of hundreds of percentages with each announcement of progress or additional achievement in the development of products on the basis of the plant. 2,500 patents are presently registered in the line and another 20 are waiting for approval. In Israel 460 patents are registered and another 10,500 are waiting for approval. The largest buyer of the patents in the line is Sanofi Avantis which has already bought 39 patents in the cannabis line, followed by Paizer with 25 patents.
20/07/2015:
One World Cannabis recently reported results of research carried out at the Sheba academic-medical center in which it was found that 60% of the common Melanoma cancer cells died within 24 hours after the team examined how they are affected by the active ingredients of the plant (THC and CBD) in various dosage. The company is in the initial stage of developing a drug based on cannabis for the treatment of cancer, but following the results it already started to develop the drug by prescription and license (in Israel) for those entitled to medical cannabis who suffer from common Melanoma. It appears subject asked One World to start negotiations for the purchase of its patents.
To OWCP's credit they did not want to report something that they were obviously not interested in pursuing, and that may have fuelled unnecessary speculation. I say good for OWCP!!!
https://www.dnb.com.tw/Report/Sample/BIR_Israel.pdf
You will find the following on page 3 of 8
20/07/2015:
Further to the info that subject approached One World Cannabis in order to
start negotiations for the purchase of patents, it should be noted that
companies engaged in the line and mainly traded on the NYSE, surge by tens of hundreds of percentages with each announcement of progress or additional achievement in the development of products on the basis of the plant. 2,500 patents are presently registered in the line and another 20 are waiting for approval. In Israel 460 patents are registered and another 10,500 are waiting for approval. The largest buyer of the patents in the line is Sanofi Avantis which has already bought 39 patents in the cannabis line, followed by Paizer with 25 patents.
20/07/2015:
One World Cannabis recently reported results of research carried out at the Sheba academic-medical center in which it was found that 60% of the common Melanoma cancer cells died within 24 hours after the team examined how they are affected by the active ingredients of the plant (THC and CBD) in various dosage. The company is in the initial stage of developing a drug based on cannabis for the treatment of cancer, but following the results it already started to develop the drug by prescription and license (in Israel) for those entitled to medical cannabis who suffer from common Melanoma. It appears subject asked One World to start negotiations for the purchase of its patents.
(1)
(0)OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼